[go: up one dir, main page]

Welbergen et al., 1982 - Google Patents

Purified Factor VIII: A high yield production method for routine Blood Banks

Welbergen et al., 1982

Document ID
10046906273325598943
Author
Welbergen H
Das P
Smit Sibinga C
Publication year
Publication venue
Bloodtransfusion and Problems of Bleeding

External Links

Snippet

The demand for factor VIII as a therapeutic material for hemophilia appears to be the main driving force in donor plasma procurement. Because of the ease of handling and the high yield cryoprecipitate is still widely produced by blood transfusion services for hemophilia …
Continue reading at link.springer.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Similar Documents

Publication Publication Date Title
Newman et al. Methods for the production of clinically effective intermediate and high‐purity factor‐VIII concentrates
US3682881A (en) Fractionation of plasma using glycine and polyethylene glycol
US5408039A (en) Process for an industrial-scale preparation of a standardized human von Willebrand factor concentrate of very high purity and suitable for therapeutic use
FI57421C (en) FOERFARANDE FOER FRAMSTAELLNING AV ETT PREPARAT UR MAENNISKOBLODPLASMA MED BLODETS KOAGULATION BEFRAEMJANDE VERKAN
Nilsson et al. Characteristics of various factor VIII concentrates used in treatment of haemophilia A
AU631471B2 (en) A method for isolating factor viii
IL42221A (en) Stabilization of ahf
US4379085A (en) Heat stabilization of plasma proteins
US4774323A (en) Purification of von Willebrand Factor solutions using gel permeation chromatography
US4397841A (en) Production of blood coagulation factor VIII:C
EP0032655A1 (en) A process in purification and concentration of the factor VIII-complex
US5006642A (en) Purification of von Willebrand Factor by affinity chromatography
Sultan et al. Platelet factor VIII-related antigen: studies in vivo after transfusion in patients with von Willebrand disease
Wickerhauser et al. Development of Large‐Scale Fractionation Methods: VI. An Improved Method for Preparation of Antihemophilic Factor 1
Welbergen et al. Purified Factor VIII: A high yield production method for routine Blood Banks
US4406886A (en) Purification of antihemophilia factor VIII by precipitation with zinc ions
Sibinga et al. Heparin and factor VIII
Holmberg et al. Factor VIII: C and VIII: CAg response in patients with haemophilia A and von Willebrand's disease after administration of different factor VIII concentrates or plasma
Finlayson Therapeutic plasma fractions and plasma fractionation (prologue)
Seghatchian et al. Absorption of factor VIII by aluminium hydroxide
US4471112A (en) Heparin polyelectrolyte polymer complex
Smit Sibinga Small-pool high-yield factor VIII production
MOIR Investigation of bleeding disorders
Mercer et al. Development of Large-Scale Fractionation Methods
Seidl Needs, quality versus quantity